阻断血红素-前列腺素受体信号减弱了人类PBMCs中脂多糖和酸诱导的炎症反应
Vinothkumar Rajamanickam1,2, Cyrus V Desouza1,2, Romilia T Castillo1,2
1Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Cells
|August 28, 2024
概括
血栓xane-prostanoid受体 (TPR) 在肥胖症中促进炎症. 阻断TPR或ROCK信号,可以降低人体免疫细胞对脂聚糖 (LPS) 和自由脂肪酸 (FFAs) 的炎症反应.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
- 细胞信号传输 细胞信号传输
背景情况:
- 炎症是肥胖相关疾病的关键因素.
- 血栓素-前列腺素受体 (TPR) 调解炎症反应.
- 肥胖与肠道衍生性脂多糖 (LPS) 和自由脂肪酸 (FFAs) 的升高有关.
研究的目的:
- 调查TPR在与肥胖相关的炎症中的作用.
- 阐明TPR影响人类免疫细胞炎症反应的机制.
- 确定TPR在调节LPS或酸 (SA) 诱导的炎症中的作用.
主要方法:
- 从患有和没有肥胖的个体的外周血液单核细胞 (PBMC) 中评估TPR mRNA水平.
- 使用了TPR信号抑制剂和激动剂.
- 研究了TPR调制对PBMCs中LPS和SA诱导的炎症反应的影响.
- 检查了ROCK信号的参与,这是TPR的下游途径.
主要成果:
- 在肥胖个体的PBMC中,TPR mRNA水平升高.
- 阻断TPR或ROCK信号减弱的LPS和/或SA诱导的炎症反应.
- 激活TPR增强了LPS和/或SA的促炎作用.
- 仅仅TPR激活就会诱导炎症反应,而TPR或ROCK阻塞则会减少炎症反应.
结论:
- TPR在促进人类PBMCs的炎症反应方面发挥着重要作用.
- 肥胖症中TPR介导的炎症涉及托尔类受体4 (TLR4) 和/或ROCK信号通路.
- 针对TPR信号可能为与肥胖相关的炎症状况提供治疗策略.
相关概念视频
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K


